Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66736-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- EPHA2 antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated EPHA2 antibody (Cat. #66736-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: FC, WB, ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1A9C3
- Vial size
- 20ul, 150ul
Submitted references EphA2 promotes the transcription of KLF4 to facilitate stemness in oral squamous cell carcinoma.
Metabolic Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through EphA2/p38 MAPK Pathway in Alzheimer's Disease.
EphA2 Promotes the Development of Cervical Cancer through the CXCL11/PD-L1 Pathway.
EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop.
EphA2 inhibits SRA01/04 cells apoptosis by suppressing autophagy via activating PI3K/Akt/mTOR pathway.
2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ) inhibits cancer cell metastasis behavior of TNBC via suppressing EMT and VEGF.
Role of Nuclear Claudin-4 in Renal Cell Carcinoma.
Bai J, Chen Y, Sun Y, Wang X, Wang Y, Guo S, Shang Z, Shao Z
Cellular and molecular life sciences : CMLS 2024 Jun 25;81(1):278
Cellular and molecular life sciences : CMLS 2024 Jun 25;81(1):278
Metabolic Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through EphA2/p38 MAPK Pathway in Alzheimer's Disease.
Ma X, Zhang Y, Gou D, Ma J, Du J, Wang C, Li S, Cui H
Journal of Alzheimer's disease : JAD 2022;88(2):771-785
Journal of Alzheimer's disease : JAD 2022;88(2):771-785
EphA2 Promotes the Development of Cervical Cancer through the CXCL11/PD-L1 Pathway.
Zhao X, Liu J, Jin D, Ren C, Yang L, Zhu Y, Huang C, Ding L, Wu Z, Shen K, Zhang Z, Chen H, Wang N
Journal of oncology 2022;2022:4886907
Journal of oncology 2022;2022:4886907
EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop.
Lin J, Zeng C, Zhang J, Song Z, Qi N, Liu X, Zhang Z, Li A, Chen F
Molecular therapy. Nucleic acids 2021 Sep 3;25:328-341
Molecular therapy. Nucleic acids 2021 Sep 3;25:328-341
EphA2 inhibits SRA01/04 cells apoptosis by suppressing autophagy via activating PI3K/Akt/mTOR pathway.
Han J, Wang L, Lv H, Liu J, Dong Y, Shi L, Ji Q
Archives of biochemistry and biophysics 2021 Oct 30;711:109024
Archives of biochemistry and biophysics 2021 Oct 30;711:109024
2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ) inhibits cancer cell metastasis behavior of TNBC via suppressing EMT and VEGF.
Zheng D, Wu Z, Han J, Guan Q, Li Z, Zuo D, Zhang W, Wu Y
Chemico-biological interactions 2020 Sep 25;329:109202
Chemico-biological interactions 2020 Sep 25;329:109202
Role of Nuclear Claudin-4 in Renal Cell Carcinoma.
Owari T, Sasaki T, Fujii K, Fujiwara-Tani R, Kishi S, Mori S, Mori T, Goto K, Kawahara I, Nakai Y, Miyake M, Luo Y, Tanaka N, Kondoh M, Fujimoto K, Kuniyasu H
International journal of molecular sciences 2020 Nov 6;21(21)
International journal of molecular sciences 2020 Nov 6;21(21)
No comments: Submit comment
No validations: Submit validation data